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Gene expression dysregulation domains are not
a speciﬁc feature of Down syndrome
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Down syndrome (DS), trisomy of human chromosome 21 (Hsa21), results in a broad range of
phenotypes. A recent study reported that DS cells show genome-wide transcriptional
changes in which up- or down-regulated genes are clustered in gene expression dysregula-
tion domains (GEDDs). GEDDs were also reported in ﬁbroblasts derived from a DS mouse
model duplicated for some Hsa21-orthologous genes, indicating cross-species conservation
of this phenomenon. Here we investigate GEDDs using the Dp1Tyb mouse model of DS,
which is duplicated for the entire Hsa21-orthologous region of mouse chromosome 16. Our
statistical analysis shows that GEDDs are present both in DS cells and in Dp1Tyb mouse
ﬁbroblasts and hippocampus. However, we ﬁnd that GEDDs do not depend on the DS
genotype but occur whenever gene expression changes. We conclude that GEDDs are not a
speciﬁc feature of DS but instead result from the clustering of co-regulated genes, a function
of mammalian genome organisation.
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Down syndrome (DS), also known as trisomy 21, is aleading cause of cognitive deﬁcits, occurring in 1 in 700births. DS results in a broad range of phenotypes,
including cognitive impairment, congenital heart defects, cra-
niofacial abnormalities and early-onset dementia1. The pre-
dominant view is that these phenotypes result from an increased
dosage of one or more of the genes on Hsa21; currently, Hsa21 is
estimated to contain 234 protein-coding genes2. The increased
dosage of these genes is predicted to lead to increased transcript
and protein levels (for the coding genes), which in turn would
affect cellular and organismal physiology resulting in the
observed pathologies. One DS pathological mechanism may be
through the action of proteins such as transcription factors or
chromatin modiﬁers that alter expression of other non-Hsa21
genes. A notable recent study proposed that trisomy 21 results in
genome-wide transcriptional changes in which upregulated or
downregulated genes are clustered in regions termed gene
expression dysregulation domains (GEDDs), with genes whose
expression changes in the same direction (up or down) being
clustered3. The study postulated that GEDDs were the result of
genome-wide chromatin changes in DS, potentially caused by
overexpression of a chromatin modiﬁer on Hsa21. The study also
reported that GEDDs were present in a mouse model of DS
named Ts65Dn that is trisomic for 132 protein-coding genes on
mouse chromosome 16 (Mmu16) that are orthologous to Hsa21.
However, the published study was limited in scope because
GEDDs were identiﬁed using four replicate RNA samples derived
from three independent ﬁbroblast cultures isolated from a single
pair of monozygotic twins discordant for trisomy 21, and the
analysis of mouse Ts65Dn ﬁbroblasts was carried out using
just one replicate3.
Evidently, such genome-wide changes in gene expression could
make a signiﬁcant contribution to DS phenotypes and thus merit
further investigation. We examined the phenomenon of GEDDs
using a recently created mouse model of DS termed Dp1Tyb,
which has three copies of the entire 23Mb region of Mmu16 that
is orthologous to Hsa21 containing 148 protein-coding genes,
including all the 132 genes duplicated in Ts65Dn4. Dp1Tyb mice
show a number of DS-like phenotypes, including congenital heart
defects4, locomotor defects5, learning and memory deﬁcits and
craniofacial abnormalities (Eva Lana-Elola, Sheona Watson-
Scales, Elizabeth M.C. Fisher and Victor L.J. Tybulewicz, 2019
unpublished).
Here we develop a robust statistical method to evaluate whe-
ther changes in gene expression are more clustered than expected
by chance, a necessary feature of GEDDs. Using this approach, we
are indeed able to detect GEDDs in both human DS ﬁbroblasts
and in Dp1Tyb mouse ﬁbroblasts and hippocampus. However,
we show that the presence of GEDDs does not depend on gen-
otype (for example, DS in humans or the Dp1Tyb duplication in
mouse) but is seen whenever gene expression changes. Indeed, we
detect GEDDs in gene expression data sets with no relation to DS
or mouse models of DS. Furthermore, we show that the bound-
aries of GEDDs correlate with boundaries of topologically asso-
ciating domains (TADs), units of higher-order chromatin
structure that are enriched in co-regulated genes6,7. We conclude
that GEDDs are not a speciﬁc feature of DS but instead result
from the organisation of mammalian genomes whereby genes
located close to each other are more likely to be co-regulated.
Results
Differential gene expression in Dp1Tyb mouse embryonic
ﬁbroblasts (MEFs). The report of GEDDs in gene expression data
from human DS ﬁbroblasts and DS induced pluripotent stem cells
(IPSCs) and from mouse Ts65Dn ﬁbroblasts (a model of DS)3
presented an opportunity to use mouse genetics to map and
identify the dosage-sensitive gene(s) causing this phenomenon.
We decided to make use of the recently described Dp1Tyb mouse
model of DS, which carries a duplication of a 23Mb region of
Mmu16 that is orthologous to Hsa21 and contains 148 protein-
coding genes4. This mouse strain has been backcrossed for well
over 10 generations such that the genetic background of all ani-
mals is C57BL/6J with <0.1% genetic variability between mice.
This duplicated region in Dp1Tyb includes all 132 Mmu16 genes
duplicated in Ts65Dn but does not have increased dosage of any
of the 43 coding genes non-orthologous to Hsa21 that are
duplicated in Ts65Dn8. Thus, if GEDDs are caused by increased
dosage of Hsa21 genes or their orthologues on Mmu16 in the
mouse, they should also be seen in cells from Dp1Tyb mice. The
Dp1Tyb strain offers a further advantage in that we have also
generated a series of strains with shorter nested duplications on
Mmu16 (Dp2Tyb to Dp9Tyb), allowing mapping of the causative
gene(s) and their eventual identiﬁcation4.
Since GEDDs had been reported in gene expression data from
human DS ﬁbroblasts and Ts65Dn MEFs, we chose to analyse
Dp1Tyb MEFs. We grew cultures of MEFs from four wild-type
(WT) and ﬁve Dp1Tyb littermate embryos, isolated RNA from
them and carried out RNA sequencing (RNAseq) in order to
quantitate gene expression. Differential gene expression analysis
showed 66 signiﬁcantly differentially expressed genes (adjusted
p value [padj] < 0.05) with 39 of these located within the
duplicated region in Dp1Tyb, all of which were upregulated
(Fig. 1, Supplementary Data 1). The mean fold change of these
duplicated genes in Dp1Tyb vs WT MEFs was 1.47, close to the
expected value of 1.5.
GEDDs in Dp1Tyb MEFs. The existence of GEDDs was pre-
viously proposed by analysing the fold change in gene expression
of DS ﬁbroblasts or IPSCs vs euploid cells and looking for clus-
tering of upregulated or downregulated genes across the genome3.
In this study, the visualisation of these domains of clustered gene
expression changes was simpliﬁed using a Loess smoothed curve.
However, the study did not determine whether the clustering of
gene expression changes seen in human DS cells was statistically
signiﬁcant. We employed a similar approach to the gene
expression data from Dp1Tyb MEFs to look for GEDDs. As
expected, we could see a clear increase of about 1.5-fold in gene
expression in Dp1Tyb MEFs across the duplicated region of
Mmu16 (Fig. 2). Across the rest of the genome, however, the fold
changes were small (Fig. 2, Supplementary Fig. 1). Notably, the
changes in gene expression were much smaller than those pre-
viously reported for the comparison between DS and euploid
human ﬁbroblasts that had led to the concept of GEDDs (Sup-
plementary Fig. 2a)3. These larger fold changes in the human data
are most likely the consequence of much greater variation in gene
expression seen in the RNAseq data (Supplementary Fig. 2b).
Nonetheless, in the analysis of the RNAseq data from Dp1Tyb
MEFs, the Loess smoothed curves showed regions of apparent
clustered upregulation or downregulation. However, the extent of
upregulation or downregulation was small, and from this analysis,
it was not possible to determine whether such clusters were sta-
tistically signiﬁcant.
To address this issue, we devised two statistical tests to
determine whether upregulated or downregulated genes were
clustered more than would be expected by chance, a necessary
feature of GEDDs. First, for each chromosome we counted the
numbers of ﬂips deﬁned as a change in the direction of the fold
change from one gene to the adjacent gene on the chromosome
(Fig. 3a). This number of ﬂips was compared to the distribution
of numbers of ﬂips determined from 100,000 permutations of the
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same chromosome with randomised orders of the genes.
Clustering of upregulated or downregulated genes would result
in a signiﬁcant decrease in the number of ﬂips compared to the
random (bootstrapped) distribution. Second, we used a spatial
correlation measure9. To this end, we calculated an energy
function E for each chromosome by multiplying the fold change
of each gene with each of its two neighbours and then adding
these products together for all genes on the chromosome (Fig. 3a).
This measure takes into account the magnitude as well as the
direction of the change of each gene and would be increased if
there were more clustering of upregulated or downregulated
genes. Again, this measure was compared to the distribution of
E of 100,000 bootstrapped versions of the same chromosome.
The presence of GEDDs would result in a larger value of E than
expected by chance.
We undertook both tests (numbers of ﬂips, energy function) on
the human DS ﬁbroblast gene expression data in Letourneau
et al., which had reported the existence of GEDDs3. On most
chromosomes, we were indeed able to detect signiﬁcantly
decreased numbers of ﬂips and increased energy compared to
the numbers expected by chance (>2 standard deviations (SDs)
from mean of randomised distribution), validating these two
approaches, and conﬁrming the presence of GEDDs statistically
(Fig. 3b, Supplementary Fig. 3, Supplementary Fig. 4, Table 1).
Next, we examined the RNAseq data from Dp1Tyb and WT
MEFs. Here again we found signiﬁcantly decreased numbers of
ﬂips and increased energy on most chromosomes, implying that
GEDDs were also present in Dp1Tyb MEFs (Fig. 3c, Supple-
mentary Fig. 5, Supplementary Fig. 6, Table 1).
GEDDs in Dp1Tyb hippocampus. The analysis by Letourneau
et al. showed a correlation in the distribution of GEDDs between
those seen in human DS and mouse Ts65Dn ﬁbroblasts3. Thus we
examined whether the same was true for gene expression changes
detected in Dp1Tyb ﬁbroblasts. However, excluding genes on
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Fig. 1 Differential gene expression in Dp1Tyb mice. Plots of log2[fold change] in the expression of each gene in Dp1Tyb mouse embryonic ﬁbroblasts
(MEFs, left) or hippocampus (right) compared to wild-type (WT) littermate controls, against mean expression of each gene. Genes are indicated by black
circles, except for differentially expressed genes (DEGs, padj < 0.05) indicated in red if they are within the duplicated region and in blue if outside it. Dashed
lines indicate a fold change of 1.5. Table at bottom shows the number of DEGs, the number of DEGs within the duplicated region in Dp1Tyb (all of which
were upregulated) and the average fold change of the latter
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Fig. 2 Change in expression in Dp1Tyb mouse embryonic ﬁbroblasts (MEFs) as a function of chromosomal position. Plots show fold change of gene
expression in Dp1Tyb MEFs vs wild-type control cells. Expressed genes are plotted in chromosomal order on the four example chromosomes. Genes that
are signiﬁcantly differentially expressed are indicated with blue dots, other genes are in grey. A Loess smoothing curve is superimposed with regions that
are upregulated or downregulated indicated in red or green. Dashed line on Mmu16 indicates a fold change of 1.5. Note the upregulation of genes in the
duplicated region on Mmu16 (thick black line)
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Hsa21 and their orthologues on Mmu16, we were able to detect
only a very small correlation in the expression changes between
orthologous genes in human DS and mouse Dp1Tyb ﬁbroblasts
(Fig. 4a). In view of this and the very small changes in gene
expression we saw between Dp1Tyb and WT MEFs (only 27
differentially expressed genes outside the duplicated region), we
wondered whether another cell type might show larger differences
in gene expression, making the correlation between human and
mouse gene expression changes easier to detect.
We decided to evaluate the gene expression changes in
hippocampus from ﬁve WT and ﬁve Dp1Tyb mice, since this
region of the brain plays an important role in learning and
memory and its function is altered in several mouse models of
DS10–17, including Dp1Tyb (Elizabeth M.C. Fisher and Victor L.J.
Tybulewicz, 2019 unpublished). Compared to the MEF expres-
sion data, we saw more changes in gene expression in the
hippocampus. There were 515 signiﬁcantly differentially
expressed genes with 76 of these located within the duplicated
region in Dp1Tyb, all of which were upregulated, and a further
439 differentially expressed genes outside the duplication (Fig. 1,
Supplementary Data 2). The mean fold change of the duplicated
genes in Dp1Tyb vs WT hippocampus was 1.41, once again close
to the expected value of 1.5. Plots of fold change of genes along
chromosomes also showed clear upregulation of genes across the
duplicated region with only small changes across the rest of the
genome (Fig. 5, Supplementary Fig. 7). Once again, the fold
changes in gene expression were much smaller than those
previously reported for the comparison between DS and euploid
human ﬁbroblasts3, most likely due to much higher variation in
gene expression in the human data (Supplementary Fig. 2a, b).
Moreover, analysis of clustering of gene expression changes
showed many chromosomes with signiﬁcantly decreased num-
bers of ﬂips and increased energy conﬁrming that GEDDs were
also detectable in the Dp1Tyb hippocampus (Supplementary
Fig. 8, Supplementary Fig. 9, Table 1).
The study reporting GEDDs in human DS ﬁbroblasts showed
that these domains were also seen in DS IPSCs with substantial
correlation in the location and magnitude of GEDDs between
these two different cell types3. Thus we examined the
correlation in gene expression changes between the Dp1Tyb
mouse hippocampus and Dp1Tyb MEFs. Excluding the
duplicated genes on Mmu16, we were able to detect only very
weak correlation (Fig. 4a). This lack of correlation was also seen
in an overlay of the Loess curves of the RNAseq data from
Dp1Tyb MEFs and hippocampus (Supplementary Fig. 10).
Furthermore, there was also very low correlation in the gene
expression changes between Dp1Tyb hippocampus and human
DS ﬁbroblasts (Fig. 4a). Taken together, these data show that
GEDDs can be detected in Dp1Tyb MEFs and hippocampus
using sensitive statistical tests, but as shown by the very poor
correlation in expression changes, the location of these is not
conserved between human DS and mouse models or indeed
between different tissues in the Dp1Tyb mouse strain.
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Fig. 3 Statistical tests for gene expression dysregulation domains. a An example plot of fold change of gene expression against chromosomal position
showing regions in which expressed genes are upregulated or downregulated (red and green, respectively). Below this are shown the directions of the fold
changes (red and green arrows) with a dashed black line indicating a ﬂip, i.e. a change in direction of the fold change. In the example shown, there are six
ﬂips. The energy function (E) is calculated by taking into account both the direction and magnitude of the fold change and is deﬁned as the sum over all
genes on the chromosome of the products of the fold change (h) of a given gene (i) with the fold change of the previous gene (i–1) and the same product
with the next gene (i+1). b Distribution of ﬂips and energy in 100,000 versions of, for example, Hsa1 each with a different randomised order of genes from
the human Down syndrome ﬁbroblast expression data3. Pink and purple lines indicate 2 and 3 standard deviations (SD) away from the mean, respectively;
dashed line shows the ﬂips and energy for the actual non-randomised chromosome. c Distribution of ﬂips and energy as described in b, for example
chromosome Mmu6 in gene expression data from Dp1Tyb and wild-type mouse embryonic ﬁbroblasts
Table 1 Human DS ﬁbroblasts3 and mouse Dp1Tyb MEFs
and hippocampus show GEDDs
Sample Number of signiﬁcant chromosomes
Flips Energy
Human DS ﬁbroblasts 20 22
Dp1Tyb MEFs 7 16
Dp1Tyb hippocampus 8 17
Table shows the numbers of chromosomes that had signiﬁcantly (>2 SD) reduced numbers of
ﬂips or increased energy in comparisons of changes in gene expression in human DS vs euploid
ﬁbroblasts or in Dp1Tyb vs WT MEFs or hippocampus
DS, Down syndrome; GEDD, gene expression dysregulation domain; MEF, mouse embryonic
ﬁbroblast
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Fig. 4 Very little correlation in gene expression changes between human Down syndrome (DS) and mouse Dp1Tyb ﬁbroblasts or hippocampus and
no preferential upregulation of lower expressed genes. a Correlation plots showing the fold change in gene expression comparing human DS vs euploid
ﬁbroblasts with Dp1Tyb vs wild-type (WT) mouse embryonic ﬁbroblasts (MEFs) or hippocampus or comparison of the Dp1Tyb MEFs with hippocampus.
Each dot is a gene (in human vs mouse comparisons orthologous genes were used). Dashed red line indicates best ﬁt regression line. Correlation
coefﬁcient r is indicated for each comparison. Hsa21 genes and their mouse orthologues were excluded from the analysis. b, c Density plots of fold
change in gene expression between Dp1Tyb vs WT MEFs (b) or hippocampus (c) (solid line) divided according to the level of gene expression: low
(0.1 < RPKM< 10), medium (10 < RPKM< 100), high (100 < RPKM). Dashed line shows similar plots of a comparison of gene expression between two
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Fig. 5 Change in expression in Dp1Tyb hippocampus as a function of chromosomal position. Plots show fold change of gene expression in Dp1Tyb vs wild-
type hippocampus. Expressed genes are plotted in chromosomal order on the four example chromosomes. Genes that are signiﬁcantly differentially
expressed are indicated with blue dots, other genes are in grey. A Loess smoothing curve is superimposed with regions that are upregulated or
downregulated indicated in red or green, respectively. Dashed line on Mmu16 plot indicates a fold change of 1.5. Note the upregulation of genes in the
duplicated region on Mmu16 (thick black line)
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GEDDs are not caused by a decreased dynamic range of gene
expression. Letourneau et al. reported that, in the comparison of
DS and euploid ﬁbroblasts, DS cells had elevated expression of
genes expressed at a low level and decreased expression of more
highly expressed genes3. Since genes tend to be clustered
according to level of expression, the authors suggest that GEDDs
may arise because of a smaller dynamic range of gene expression
in DS cells compared to euploid cells, leading to clustered
increases in gene expression of lowly expressed genes and clus-
tered decreases of highly expressed genes. In view of this, we
examined the gene expression changes in Dp1Tyb MEFs and
hippocampus compared to WT controls as a function of gene
expression level. Following the approach used by Letourneau
et al.3, we divided genes into low, medium and high levels of
expression and evaluated the distribution of fold changes in gene
expression between Dp1Tyb and WT MEFs or hippocampus in
comparison to the control of comparing WT to WT expression.
We saw no evidence for increased or decreased fold changes in
Dp1Tyb cells in the lowly or highly expressed genes, respectively
(Fig. 4b, c). Thus there is no change in the dynamic range of gene
expression in Dp1Tyb MEFs or hippocampus, and this cannot
explain the GEDDs in these cell types.
GEDDs are not due to increased mRNA levels in Dp1Tyb cells.
A recent study by Mowery et al. demonstrated that interleukin-7-
cultured pro-B cells from Ts1Rhr mice had increased levels of
mRNA compared to WT controls18. This mouse strain has a
duplication of a 33-gene Hsa21-orthologous region on Mmu16,
which is entirely included within the duplication in Dp1Tyb
mice4,19. The study demonstrated that this increase in mRNA is
caused by an additional copy of the Hmgn1 gene, which codes for
HMGN1, a nucleosome-binding protein that modulates chro-
matin compaction. Furthermore, the increase in mRNA level was
not even, with a larger increase in lower expressed genes and a
smaller increase in the more highly expressed genes. The authors
argue that, in a standard RNAseq analysis that assumes no change
in overall RNA levels and is normalised to median read counts
(relative normalisation), this uneven increase in RNA levels
would lead to an apparent increase in the expression of lower
expressed genes and decrease in the expression of higher
expressed genes. This in turn would result in the appearance of
GEDDs because of the tendency for genes to be clustered
according to the level of expression. Since the Hmgn1 gene is
duplicated in Dp1Tyb mice and signiﬁcantly increased in the
expression in both Dp1Tyb MEFs and hippocampus (Supple-
mentary Data 1, 2), it is possible that the GEDDs we observed in
tissues from these mice might also be a consequence of increased
mRNA levels and the use of relative normalisation. To address
this possibility, we carried out another RNAseq experiment on
Dp1Tyb and WT MEFs, but this time added non-mammalian
synthetic ERCC (External RNA Controls Consortium) RNA
controls at a ﬁxed amount per cell to each sample, similar to the
strategy employed by Mowery et al.18. To determine whether
the overall amount of mRNA was increased in Dp1Tyb MEFs, we
analysed the data by normalising to the spiked-in ERCC controls
(absolute normalisation) and compared this to relative normal-
isation of the same data. We found that the mean fold change of
gene expression between Dp1Tyb and WT MEFs was ~1.8%
higher using absolute normalisation compared to relative nor-
malisation, indicating a small increase in overall mRNA level in
Dp1Tyb MEFs (Supplementary Fig. 11a). This is much less than
the ~10% increase seen by Mowery et al. in Ts1Rhr pro-B cells18
and may be partly accounted for by the increase in the tran-
scriptome in Dp1Tyb cells compared to WT cells (~0.7%).
Importantly, we could see no skewed increase in expression in
favour of lower expressed genes (Supplementary Fig. 11b), thus
an increase in mRNA level cannot explain the GEDDs detected
in these cells.
GEDDs are not caused by DS genotype. In view of the very low
correlation between the human and mouse gene expression
changes and the very small magnitude of these changes in both
Dp1Tyb MEFs and hippocampus, we wondered whether the
expression changes contributing to the detection of GEDDs were
due to experimental variation and not to the human or mouse DS
genotype. To address this, we repeated the analysis of the
expression data from both the human DS ﬁbroblasts3 and the
mouse Dp1Tyb MEFs and hippocampus but mixed samples so as
to eliminate the effect of genotype. The human DS ﬁbroblast data
consisted of four DS samples and four euploid samples. Thus we
compared two DS and two euploid samples against two other DS
and two other euploid samples, thereby eliminating the effect of
genotype in the comparison. With 4 DS and 4 euploid samples,
there are 18 possible combinations in which such no genotype
difference comparisons could be carried out, and we calculated
fold changes in gene expression for all of these. Similar switching
was carried out with the Dp1Tyb MEF and hippocampus data.
Plotting the fold changes superimposed on Loess smoothing
curves from the genotype-switched analysis of the human DS
ﬁbroblasts suggested the presence of GEDDs, for example on
Hsa21 (Fig. 6a, b). Analysis of GEDDs using the ﬂips and energy
measures showed that, for many chromosomes in most of the
switched no-genotype-difference analyses, there were signiﬁcantly
reduced numbers of ﬂips and increased energy, indicating
GEDDs (Fig. 6c, d). Similarly, eliminating the genotype
contribution in the mouse Dp1Tyb MEF and hippocampus data
by switching genotypes still showed that in most of the switched
combinations most chromosomes had detectable GEDDs as
measured by ﬂips or energy (Fig. 7a–h, Supplementary Fig. 12
and 13). Thus we conclude that clustering of upregulated or
downregulated genes (i.e. GEDDs) is detectable even when there
is no difference in genotype between the samples being compared
and, in this case, is most likely due to small variations in gene
expression from one ﬁbroblast culture to another or from one
mouse to another. Furthermore, this implies that GEDDs may
not be a speciﬁc feature of DS.
GEDDs caused by genetic changes unrelated to DS. If GEDDs
are not speciﬁcally caused by the DS genotype but are detected
when expression changes are due to other causes, it may be that
they are a general phenomenon occurring whenever the expres-
sion of genes changes. To address this, we turned to a completely
unrelated RNAseq data set that one of us (H.A.) had previously
worked on, consisting of gene expression in follicular and mar-
ginal zone B cells taken from mice with a null mutation of the
Zfp36l1 gene or from WT control mice20. We carried out three
differential gene expression analyses, comparing WT and
ZFP36L1-deﬁcient follicular B cells, WT and ZFP36L1-deﬁcient
marginal zone B cells and WT follicular with WT marginal zone
B cells. All three of these comparisons identiﬁed substantial
numbers of differentially expressed genes20. Plots of fold changes
in gene expression with Loess smoothing curves indicated the
possible locations of clustered gene expression changes (Supple-
mentary Fig. 14, and data not shown). Furthermore, analysis of
clustering of gene expression changes once again showed many
chromosomes with signiﬁcantly decreased numbers of ﬂips and
increased energy conﬁrming that GEDDs were also detectable in
each of these three comparisons (Table 2). Thus we conclude that
GEDDs are caused by perturbations in gene expression that are
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10129-9
6 NATURE COMMUNICATIONS |         (2019) 10:2489 | https://doi.org/10.1038/s41467-019-10129-9 | www.nature.com/naturecommunications
unrelated to DS and hence are not a speciﬁc feature of the
syndrome.
GEDD boundaries align with TAD boundaries. Finally, we
considered the relationship of the GEDDs that we had detected in
Dp1Tyb MEFs and hippocampus with previously described
genomic domains that relate to gene expression. TADs are
regions of the genome showing increased intra-domain interac-
tions compared to inter-domain interactions6,7. TADs appear to
be loops of chromatin held together at their ends, one con-
sequence of which is that genes within TADs are more likely to be
co-regulated21–23. The boundaries of TADs are often marked by
binding of the CTCF protein, which may be involved in the
formation of TADs6. These boundaries also often correspond to
the boundaries of replication domains, regions of either early or
late replication24. Finally, some regions of the genome have been
found to associate with the nuclear lamina. These lamina-
associated domains (LADs) are typically regions of gene repres-
sion and correspond partially to TADs, though generally LADs
are larger than TADs25. We compared the location of these
elements relative to GEDDs and found that TAD boundaries
and CTCF binding sites were enriched at GEDD boundaries
from both Dp1Tyb MEFs and hippocampus (Fig. 8a, c).
In contrast, there was no obvious enrichment of replication
domain or LAD boundaries. Inverting the comparison, we found
that GEDD boundaries and CTCF-binding sites were enriched at
TAD boundaries, as were replication domain and LAD bound-
aries, although to a lower extent (Fig. 8b, d). Thus we conclude
that the co-regulation of gene expression in GEDDs is most likely
a consequence of their partial correspondence to TADs, genomic
structures that tend to contain co-regulated genes.
Discussion
The recent report that DS cells show clustered upregulation or
downregulation of gene transcription compared to euploid cells, a
phenomenon termed GEDDs, gave rise to the hypothesis that at
least some DS phenotypes may be caused by chromatin changes
leading to genome-wide dysregulation of gene expression3. This is
an important hypothesis to address in the context of trying to
understand the pathological mechanisms that underpin DS phe-
notypes, since it suggests that some phenotypes may be the result
of widespread changes of gene expression across the genome,
rather than direct effects of increased expression of one or a few
Hsa21 genes. The observation that GEDDs were also reported in
the Ts65Dn mouse model of DS presented us with an opportunity
to use the Dp1Tyb mouse strain and, potentially, the associated
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mapping panel of mouse duplication strains (Dp2Tyb to
Dp9Tyb)4 to locate and identify the dosage-sensitive gene(s) that
give rise to GEDDs, and hence, ultimately, to test the importance
of GEDDs in causing DS phenotypes.
We developed two statistical tests to conﬁdently detect clus-
tering of gene expression changes occurring in the same direction
and using these were able to show GEDDs in the gene expression
data from human DS ﬁbroblasts reported by Letourneau et al.3.
We were also able to detect GEDDs in our own gene expression
data from Dp1Tyb MEFs and hippocampus. However, the loca-
tion of the expression changes was not conserved between the
human and mouse data. We noted that the magnitude of the gene
a
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expression changes was larger in the human DS ﬁbroblast data
compared to the Dp1Tyb mouse ﬁbroblast and hippocampus
data. This difference may arise from the greater number of bio-
logical replicates used in our mouse studies compared to the
original human DS ﬁbroblast data3. This is supported by the
larger variation in gene expression, i.e. more noise, in the human
ﬁbroblast data compared to our Dp1Tyb mouse ﬁbroblast and
hippocampus data.
Letourneau et al. had previously suggested that GEDDs may be
caused by a smaller dynamic range of gene expression in DS cells
with increased expression of lower expressed genes and decreased
expression of higher expressed genes3. We saw no such effect in
Dp1Tyb MEFs or hippocampus. More recently, Mowery et al.
showed that an additional copy of the Hmgn1 gene results in an
increase in total RNA in mouse pro-B cells, with a larger increase
in lower than in higher expressed genes18. They suggested that,
because of this, the appearance of GEDDs in DS cells was an
illusion caused by the use of relative normalisation of RNAseq
data to the median gene expression in a sample. To test this idea,
we carried out RNAseq on Dp1Tyb and WT MEFs with control
spike-in RNAs, which allows an absolute normalisation of the
data to the spike-ins, thereby determining absolute RNA levels.
We found a small increase in RNA levels in Dp1Tyb MEFs, but
this increase was not skewed towards the lower expressed genes
and thus cannot explain the GEDDs we observe. This result
agrees with our observation, discussed above, that using a relative
normalisation there was no increased expression of lower
expressed genes and decreased expression of higher expressed
genes. We note that, despite an additional copy of the Hmgn1
gene in Dp1Tyb MEFs and ~1.5-fold increased expression of the
gene, the increase in RNA level was much smaller than that seen
in Ts1Rhr pro-B cells, suggesting that the effects of Hmgn1
overexpression may be cell-type speciﬁc.
Importantly, using two different approaches, we were able to
show that the presence of GEDDs was not dependent on the DS
genotype. First, we mixed samples and carried out differential
gene expression analysis between sets of samples that no longer
differed by DS genotype; this analysis still detected GEDDs.
Second, we were able to detect GEDDs in an unrelated RNAseq
data set comparing gene expression in B cells from WT and
ZFP36L1-deﬁcient mice. Thus we conclude that GEDDs are not a
speciﬁc feature of DS but rather this spatial coordination of
expression in the genome is seen whenever gene expression
changes, even if this is caused by small stochastic variations in
gene expression.
A recent publication by Do et al. questioned the validity of
GEDDs in DS, based on an inability to reproduce the gene
expression changes in human IPSCs and Ts65Dn MEFs reported
by Letourneau et al.26. This report points out that gene expression
data on the same DS IPSCs had been previously published by the
same group27, but analysis of this latter data showed very little
correlation in gene expression changes with the data in Letour-
neau et al.26. Furthermore, Do et al. also carried out RNAseq
on Ts65Dn and control MEFs and showed that it did not cor-
relate with the gene expression changes reported in Ts65Dn
MEFs by Letourneau et al.26. Taken together, Do et al. suggest
that GEDDs are not a reproducible feature of human DS IPSCs or
of ﬁbroblasts from the Ts65Dn mouse model of DS. These dif-
ferences in gene expression changes may be a result of experi-
mental variation; we note that the Letourneau et al.’s study used
only three biological replicates for the RNAseq data from DS
ﬁbroblasts and only one replicate from DS IPSCs and Ts65Dn
mouse ﬁbroblasts3.
Our data show that, irrespective of whether the reported gene
expression changes are caused by the DS genotype or by
experimental variation, whenever gene expression changes
between two different conditions, the upregulated or down-
regulated expression changes are clustered to a greater extent
than would be expected by chance. This clustering of gene
expression changes is likely to be caused by the non-random
arrangement of genes in the mammalian genome. It has been
recognised for some time that co-expressed genes are more likely
to be located near each other in the genome28. Co-expressed
mammalian genes are clustered at different scales, both at the
level of neighbouring genes and in domains spanning many
megabases29,30. In particular, TADs are genomic domains that
are formed by chromatin loops and are often bounded by CTCF-
binding sites6,7. As a consequence of increased intra-domain
interactions in TADs, genes within them are more likely to be co-
regulated21–23. We found that the boundaries of TADs and
CTCF-binding sites were enriched at the boundaries of GEDDs,
suggesting that GEDDs at least partially correspond to TADs.
This observation explains why we detect a statistically signiﬁcant
increase in clustering of gene expression changes.
Fig. 7 Gene expression dysregulation domains do not depend on the genotype of mouse models of Down syndrome (DS). a Fold change in gene expression
on Mmu16 from a comparison of Dp1Tyb and wild-type (WT) mouse embryonic ﬁbroblasts (MEFs). Expressed genes (grey dots) are plotted in
chromosomal order. A Loess smoothing curve is superimposed with regions that are upregulated or downregulated indicated in red or green, respectively.
Dashed line indicates a fold change of 1.5 and the thick black line indicates the duplicated region in Dp1Tyb mice. This is the same as the plot of Mmu16 in
Fig. 2. b Same as a, but fold changes of gene expression on Mmu16 are from a no-genotype-difference comparison of two WT and two Dp1Tyb MEFs vs
two other WT and two other Dp1Tyb MEFs. c, d Plots of ﬂips (c) and energy (d) for comparisons of all possible no-genotype-difference combinations of
WT and Dp1Tyb MEF samples. Each dot is a comparison of different combinations of samples, with blue indicating combinations that are signiﬁcantly
different (>2 SD) from the mean of bootstrapped chromosomes and black for not signiﬁcant. Horizontal lines indicate the values obtained for the correct
comparison of four DS vs four euploid samples (red, signiﬁcant; black, not signiﬁcant). e Fold change in gene expression on Mmu16 from a comparison of
Dp1Tyb and WT hippocampus; identical to ﬁgure of Mmu16 shown in Fig. 5. f Same as e, but fold changes of gene expression on Mmu16 are from a no-
genotype-difference comparison of two WT and two Dp1Tyb hippocampus vs two other WT and two other Dp1Tyb hippocampus. g, h Analysis of the
distribution of gene expression changes in no-genotype comparisons for Dp1Tyb and WT mouse hippocampus data. Plots as in c and d
Table 2 GEDDs observed in B cells null for ZFP36L1
Sample Number of signiﬁcant chromosomes
Flips Energy
ZFP36L1-deﬁcient vs WT
follicular B cells
8 13
ZFP36L1-deﬁcient vs WT
marginal zone B cells
5 8
Follicular vs marginal zone WT
B cells
4 10
Table shows the numbers of chromosomes that had signiﬁcantly (>2 SD) reduced numbers of
ﬂips or increased energy in comparisons of changes in gene expression in ZFP36L1-deﬁcient vs
WT follicular or marginal zone B cells or in follicular vs marginal zone WT B cells
GEDD, gene expression dysregulation domain; WT, wild type
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In summary, our results show that GEDDs are not a speciﬁc
feature of DS, but are detected whenever gene expression changes,
and are most likely a direct consequence of clustering of co-
expressed genes in the mammalian genome.
Methods
Mice. C57BL/6J.129P2-Dp(16Lipi-Zbtb21)1TybEmcf/Nimr (Dp1Tyb) mice4 were
bred at the MRC National Institute for Medical Research (now part of the Francis
Crick Institute). All mice were backcrossed to C57BL/6JNimr for at least ten
generations. MEFs were derived from ﬁve Dp1Tyb and four WT littermate E14.5
embryos. For the hippocampal RNAseq experiments, the whole hippocampus was
dissected from 5 Dp1Tyb and 5 WT littermate male mice aged 18.5–19 weeks.
All animal work was approved by the Ethical Review panel of the Francis Crick
Institute and was carried out under Project Licences granted by the UK Home
Ofﬁce.
Cell culture. For the generation of MEFs, E14.5 embryos were decapitated,
eviscerated, minced and then treated with trypsin. Embryos were then titurated to
obtain a single-cell suspension. Cells were cultured in Dulbecco’s modiﬁed Eagle’s
medium (Gibco), 10% foetal bovine serum, 1× penicillin/streptomycin (Gibco)
and 50 μM 2-mercaptoethanol (Gibco). MEFs were cultured for two passages and
then prepared for RNA extraction by trypsinisation to remove them from the
culture plates.
RNA preparation, library preparation and sequencing. Total RNA was puriﬁed
from MEFs using Trizol (Life Technology) following the manufacturer’s instruc-
tions. Where RNA spike-ins were used, 4 μl of a 1:100 dilution of ERCC RNA
spike-in mix 1 (ThermoFisher), was added to 200,000 MEFs re-suspended in Trizol
prior to RNA extraction. The MEF/spike-in/Trizol mixture was then extracted
following the manufacturer’s instructions. Hippocampus was homogenised in
Qiazol using a TissueRuptor II with disposable probes (Qiagen). RNA was
extracted from the homogenised samples using the miRNeasy Kit (Qiagen) fol-
lowed by treatment with Turbo DNAse (Ambion). RNA concentrations were
measured using the Qubit 3 (Life Technologies) or the NanoDrop ND-1000 and
RNA quality was assessed using the Bioanalyzer or the Tapestation 2200 (Agilent).
Samples with a RNA integrity number >8.5 were taken forward for sequencing.
RNAseq libraries were prepared with the TruSeq Stranded mRNA Sample Prep Kit
(Illumina). Libraries were sequenced with an Illumina HiSeq 2500 using a 100 base
paired-end protocol (MEFs) or with a HiSeq 4000 using a 75 base paired-end
protocol (hippocampus) or 100 base paired-end protocol (MEFs with spike-ins).
Analysis of RNAseq data. The quality of the sequencing data was assessed using
FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and illu-
strated using the multiqc tool31 (Supplementary Fig. 15a–c). The adapter sequences
were trimmed using TrimGalore! and the reads were mapped to the genome
assembly GRCm38 using TopHat (version 2.0.12)32. Multialigning reads were
discarded. Reads mapping to genes were counted using htseq-count33. A R/bio-
conductor package DESeq2 was used for analysis of differentially expressed
genes34. Genes were considered as signiﬁcantly differentially expressed between
mutant and WT conditions when padj < 0.05. Data with the ERCC spike-ins was
processed as described above with the following differences: data were mapped to
the genome assembly amended with sequences of the ERCC synthetic spike-in
RNAs (ThermoFisher) and was normalised using spike-ins before analysing dif-
ferentially expressed genes using a R/Bioconductor package DESeq2. For each
RNAseq sample, the total number of reads, as well as the number and percentage
of unique and aligned pairs of sequences, are shown in Supplementary Fig. 15d.
For no-genotype-difference analysis, four samples of each genotype were used
and their genotypes were mixed so that in each case we compared gene expression
in two WT and two mutant samples against the gene expression of two other WT
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Fig. 8 Boundaries of gene expression dysregulation domains (GEDDs) correlate with boundaries of topologically associating domains (TADs) and CTCF-
binding sites. a Probability density plot showing the distribution of boundaries of TADs, lamina-associated domains (LADs) and replication domains (RDs)
and CTCF-binding sites, all from mouse embryonic ﬁbroblasts (MEFs), relative to a region of ±2.2Mb around GEDD boundaries derived from the
comparison of Dp1Tyb and wild-type (WT) MEFs. b Same elements as in a compared relative to TAD boundaries. c Density plot showing the distribution of
boundaries of TADs from the cortex, boundaries of LADs and RDs from neural precursor cells and CTCF-binding sites from hippocampus relative to GEDD
boundaries derived from the comparison of Dp1Tyb and WT hippocampus. d Same elements as in c compared relative to TAD boundaries
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and two other mutant samples. With 4 WT and 4 mutant samples, there are 18
possible ways to make such comparisons where there is no difference in genotype
between the groups of samples being compared; we calculated the expression
changes in all such 18 combinations. Expressed genes were ﬁltered using a cutoff
value, which was determined by calculating the mean RPKM value for each gene,
plotting the log2 transformed values as a density plot and then ﬁtting a normal
distribution to estimate the mean and SD, similar to a previously published
approach35. Genes with a log2[RPKM] value bigger than mean− (3 × SD) were
considered as expressed. R/Bioconductor was used to calculate all statistical tests
(Loess smoothing function and Pearson correlation) and to visualise the data (fold
change, correlation and density plots).
Statistical analysis of GEDDs. Statistical signiﬁcance of the existence of GEDDs
in chromosomes was determined by using ﬂip number and energy metrics for false
discovery rate (FDR) calculations. A ﬂip metric for each chromosome was calcu-
lated by applying the following function over all genes in a chromosome:
F ¼P
N
i
1; sign hið Þ≠signðhi1Þ
0; otherwise

, where F is total number of ﬂips, N is number of
genes, and h is gene expression fold-change between two conditions taken from
RNAseq experiments. A signiﬁcantly low number of ﬂips in the chromosome
indicates the likely presence of GEDDs. The energy metric is deﬁned as a sum of
every gene interacting with its neighbouring genes: E ¼PNi hi ´ hi1 þ hi ´ hiþ1
where E is total energy. A signiﬁcantly high energy indicates the likely presence of
GEDDs on a chromosome. An FDR calculation was performed by permuting the
order of all genes in a given chromosome 100,000 times and then calculating ﬂip
and energy metrics for each permutation. This action creates normal distributions
of these two metrics for each chromosome. Flip and energy metric values of the
original gene order were placed within these distributions and were considered to
be signiﬁcant if they lay >2 SDs from the mean (FDR < 4.55% of event occurring
randomly). Hsa21 was excluded from this analysis of human DS ﬁbroblast data and
genes in the duplicated region of Mmu16 were excluded from analysis of Dp1Tyb
MEFs and hippocampus.
Alignment of GEDDs with other genomic elements. A GEDD was deﬁned as a
set of two or more expressed, adjacent and similarly regulated (either positive or
negative log2[fold change] values) genes. The boundaries of GEDDs were deﬁned
as being half way between two genes with opposite directions of fold change since
we have no way of deﬁning the location of these boundaries more precisely. The
boundaries of GEDDs from MEFs were compared to the boundaries of TADs
(Gene Expression Omnibus (GEO): GSE104367)36, LADs (GEO: GSE17051)37 and
replication domains (GEO: GSM450292)38, all from MEFs and to CTCF-binding
sites from MEFs (GEO: GSE104427)36. The boundaries of GEDDs from mouse
hippocampus were compared to the boundaries of TADs from the mouse cortex
(GEO: GSE35156)39, to LADs (GEO: GSE17051)37 and replication domains (GEO:
GSM450284)40 from mouse neural precursor cells and to CTCF-binding sites from
the mouse hippocampus (GEO: GSE84174)41. For each of these chromatin features,
their relative distance to a GEDD or TAD boundary was calculated within a
window of ±2.5 Mb around the boundary. The boundary orientation was con-
sidered for these two domains. A chromatin feature identiﬁed downstream of the
start of the GEDD or TAD domain or upstream of the end of the domain was given
a positive distance, whereas a feature upstream of the start of the domain or
downstream of the end of the domain was given a negative distance. The Gaussian
kernel density estimates were computed for the relative distances using the density
function with default parameters in the stats R package.
Numbers of genes. Numbers of coding genes were determined using Biomart in
Ensembl (mouse genome assembly GRCm38.p5) ﬁltering for protein-coding as
gene type.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All relevant data supporting the key ﬁndings of this study are available within the article
and its Supplementary Information ﬁles or from the corresponding author upon
reasonable request. All RNAseq data has been deposited in the Gene Expression
Omnibus, accession number GSE109295. A reporting summary for this article is
available as a Supplementary Information ﬁle.
Code availability
Scripts for calculating ﬂips and energy are freely available on GitHub (https://github.
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